Written Question: Safety of the AZD1222 vaccine

(Source: European Parliament)

Date submitted: 23 March 2021

Question for written answer E-001601/2021
to the Commission
Rule 138
Roman Haider (ID), Georg Mayer (ID)

Subject: Safety of the AZD1222 vaccine

On 29 January 2021, the Commission ‘conditionally’ authorised the AZD1222 vaccine in the EU(1).

Recently, a number of deaths have been reported in connection with a ‘coronavirus vaccination’. For example, the Italian judicial authorities are investigating at least six deaths which might be linked to the AstraZeneca vaccine(2).

According to an article published in the medical journal ‘aerzteblatt.de’(3), the use of this vaccine is deeply unethical, even if patients are informed about the risks.

  1. In the Commission’s view, are these views and deaths enough to call the safety of the vaccine into question?
  2. What would constitute grounds for the Commission to withdraw its authorisation?
  3. Does the Commission believe that this vaccine was incorrectly assessed during its approval process?

(1) https://ec.europa.eu/commission/presscorner/detail/en/ip_21_306
(2) https://www.tt.com/artikel/30785118/todesfaelle-in-italien-behoerden-dehnen-ermittlungen-zu-impfungen-aus
(3) https://www.aerzteblatt.de/archiv/217993/AstraZeneca-Impfstoff-Hohes-Risiko

%d bloggers like this: